Portal de investigación
A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Serra-Guillén C
- Traves V
- Llombart B
Abstract
Photodynamic therapy (PDT) and imiquimod are the treatments of choice for actinic keratosis (AK). As they have different mechanisms of action, it seems reasonable to assume that applying both treatments sequentially would be efficacious.
Datos de la publicación
- ISSN/ISSNe:
- 0190-9622, 1097-6787
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 22226430
- Factor de Impacto:
- 1,902 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY MOSBY-ELSEVIER
Citas Recibidas en Web of Science: 64
Documentos
- No hay documentos
Filiaciones
Cita
Serra C,NAGORE E,HUESO L,Traves V,MESSEGUER F,SANMARTÍN O,Llombart B,REQUENA C,BOTELLA R,GUILLÉN C. A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes. J. Am. Acad. Dermatol. 2012. 66. (4):e131-7. IF:4,906. (1).